Back to MDGL
Hennion & Walsh Asset Management, Inc. → MDGL
Hennion & Walsh Asset Management, Inc. MDGL Position History
Madrigal Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$4.2M
Q3 2026
Peak value
$5.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $5.9M |
| Q4 2025 | $4.8M |
| Q1 2026 | $4.5M |
| Q2 2026 | $4.7M |
| Q3 2026 | $4.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.2M | 8.4K | — | — |
| Q2 2026 | $4.7M | 8.7K | — | — |
| Q1 2026 | $4.5M | 8.6K | — | — |
| Q4 2025 | $4.8M | 8.2K | — | — |
| Q3 2025 | $5.9M | 12.8K | — | — |
Other funds holding MDGL
$728.8M
$719.5M
$319.1M
$283M
$283M
$237.6M
$212.9M
$212.9M